Ganipatide

Ganipatide is a 1-31-Glucose-dependent insulinotropic polypeptide. Ganipatide is promising for research of diabetes[1].

2758595-29-6

12352209

Peptide-Drug Conjugates (PDCs)

Antibody-drug Conjugate/ADC Related

Metabolic Disease

O=C([C@H](NC(C)=O)CC1=CC=C(O)C=C1)NC(C)(C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N2[C@H](C(N)=O)CCC2)=O)CCCCN)=O)CCC(N)=O)=O)C)=O)CC(C)C)=O)CC(C)C)=O)CC3=CNC4=CC=CC=C34)=O)CCCCNC(CC[C@H](NC(CC[C@H](NC(CC[C@H](NC([C@]5(CC[C@@H](CC5)CNC(CCCCCCCCCCCCCCCCCCC(O)=O)=O)[H])=O)C(O)=O)=O)C(O)=O)=O)C(O)=O)=O)=O)C(C)C)=O)CC6=CC=CC=C6)=O)CC(O)=O)=O)CCC(N)=O)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)[C@H](CC)C)=O)CCCCN)=O)CC(O)=O)=O)CCCC)=O)C)=O)[C@H](CC)C)=O)CO)=O)CC7=CC=C(O)C=C7)=O)CC(O)=O)=O)CO)=O)[C@H](CC)C)=O)CC8=CC=CC=C8)=O)[C@@H](C)O)=O)=O)CCC(O)=O)=O)C

C216H334N46O61

4551.23

[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P10881/

Peptides

No Development Reported